An E-factor minimized solvent-free protocol
519
4.20 (q, 2H, H9), 7.44–7.70 (m, 5H, Ph) ppm; 13C NMR
(100 MHz, CDCl3): d = 13.9 (C10), 42.8 (C4), 43.5 (C7),
61.5 (C9), 91.7 (q, 2J = 34 Hz, C5), 123.0 (q,
1J = 287 Hz, CF3), 126.6, 128.9, 129.5, 131.3 (C–Ar),
153.6 (C3), 166.6 (C6, C=O), 167.7 (C8, C=O) ppm; MS
(EI, 70 eV): m/z (%) = 344 (M?, 19), 299 (12), 230 (84),
161 (100), 103 (13).
Ethyl 3-(2-furanyl)-4,5-dihydro-5-hydroxy-b-oxo-5-
(trifluoromethyl)-1H-pyrazole-1-propanoate
(3j, C13H13F3N2O5)
1
Yield 72%; m.p.: 91–93 °C; H NMR (200 MHz, CDCl3):
2
d = 1.26 (t, 3H, H10), 3.51 (d, 1H, J = 18.6 Hz, H4a),
3.68 (d, 1H, 2J = 18.6 Hz, H4b), 3.76 (d, 1H,
2J = 17.1 Hz, H7a), 3.85 (d, 1H, 2J = 16.1 Hz, H7b),
4.21 (q, 2H, H9), 6.04 (br s, 1H, OH), 6.55 (q, 1H, H13),
6.86 (d, 1H, H12), 7.58 (d, 1H, H14) ppm; 13C NMR
(100 MHz, CDCl3): d = 13.9 (C10), 42.4 (C4), 43.2 (C7),
61.4 (C9), 91.2 (q, 2J = 35 Hz, C5), 123.0 (q,
1J = 288 Hz, CF3), 112.2, 113.6, 145.1, 145.4 (2-furanyl),
145.2 (C3), 166.5 (C6, C=O), 167.8 (C8, C=O) ppm; MS
(EI, 70 eV): m/z (%) = 334 (M?, 25), 289 (11), 220 (100),
151 (79).
Ethyl 4,5-dihydro-5-hydroxy-3-(4-methylphenyl)-b-oxo-5-
(trifluoromethyl)-1H-pyrazole-1-propanoate
(3g, C16H17F3N2O4)
1
Yield 79%; m.p.: 58–60 °C; H NMR (200 MHz, CDCl3):
d = 1.23 (t, 3H, H10), 2.40 (s, 3H, CH3), 3.53 (d, 1H,
2J = 18.5 Hz, H4a), 3.70 (d, 1H, 2J = 18.7 Hz, H4b), 3.76
2
2
(d, 1H, J = 16.1 Hz, H7a), 3.85 (d, 1H, J = 16.1 Hz,
H7b), 4.20 (q, 2H, H9), 6.00 (br s, 1H, OH), 7.24 (d,
3J = 8 Hz, 2H, H–Ar), 7.56 (d, 3J = 8 Hz, 2H, H–
Ar) ppm; 13C NMR (100 MHz, CDCl3): d = 13.9 (C10),
21.4 (C15), 42.8 (C4), 43.5 (C7), 61.4 (C9), 91.6 (q,
2J = 34 Hz, C5), 123.0 (q, 1J = 287 Hz, CF3), 126.6,
126.8, 129.5, 141.8 (C–Ar), 153.6 (C3), 166.6 (C6, C=O),
167.6 (C8, C=O) ppm; MS (EI, 70 eV): m/z (%) = 358
(M?, 23), 313 (12), 244 (97), 175 (100).
Ethyl 4,5-dihydro-5-hydroxy-3-(naphthalen-2-yl)-
b-oxo-5-(trifluoromethyl)-1H-pyrazole-1-propanoate
(3k, C19H17F3N2O4)
Yield 87%; m.p.: 110–113 °C; 1H NMR (200 MHz,
CDCl3): d = 1.25 (t, 3H, H10), 3.68 (d,1H, 2J =
2
18.9 Hz, H4a), 3.86 (d, 1H, J = 18.7 Hz, H4b), 3.81 (d,
1H, 2J = 16.1 Hz, H7a), 3.91 (d, 1H, 2J = 16.1 Hz, H7b),
4.22 (q, 2H, H9), 6.01 (br s, 1H, OH), 7.51-7.93 (m, 7H, H–
Ar) ppm; 13C NMR (100 MHz, CDCl3): d = 13.9 (C10),
Ethyl 3-(4-fluorophenyl)-4,5-dihydro-5-hydroxy-
b-oxo-5-(trifluoromethyl)-1H-pyrazole-1-propanoate
(3h, C15H14F4N2O4)
2
42.8 (C4), 43.4 (C7), 61.5 (C9), 91.8 (q, J = 34 Hz, C5),
1
123.0 (q, J = 287 Hz, CF3),122.6, 127.0, 127.1, 127.7,
1
Yield 83%; m.p.: 82–84 °C; H NMR (200 MHz, CDCl3):
127.8, 127.9, 128.5, 128.8, 132.7, 134.4 (C–Ar), 153.6
(C3), 166.6 (C6, C=O), 167.7 (C8, C=O) ppm; MS (EI,
70 eV): m/z (%) = 394 (M?, 35), 349 (10), 280 (100), 211
(79), 153 (18).
d = 1.24 (t, 3H, H10), 3.54 (d, 1H, 2J = 19 Hz, H4a), 3.70
(d, 1H, 2J = 19 Hz, H4b), 3.76 (d, 1H, 2J = 16.1 Hz,
2
H7a), 3.85 (d, 1H, J = 16.1 Hz, H7b), 4.20 (q, 2H, H9),
5.98 (br s, 1H, OH), 7.09–7.64 (m, 4H, H–Ar) ppm; 13C
NMR (100 MHz, CDCl3): d = 13.9 (C10), 42.8 (C4), 43.5
(C7), 61.5 (C9), 91.8 (q, 2J = 34 Hz, C5), 116.2 (d,
Ethyl 3-(biphenyl-4-yl)-4,5-dihydro-5-hydroxy-
b-oxo-5-(trifluoromethyl)-1H-pyrazole-1-propanoate
(3l, C21H19F3N2O4)
1
2J = 22.7 Hz, C–Ar), 123.0 (q, J = 287 Hz, CF3), 125.9
(d, 4J = 2.9 Hz, C–Ar), 128.8 (d, 3J = 8.8 Hz, C–Ar),
152.6 (C3), 164.5 (d, 1J = 253.2 Hz, C14), 165.8 (C6,
C=O), 167.7 (C8, C=O) ppm; MS (EI, 70 eV): m/z
(%) = 362 (M?, 5), 317 (5), 248 (63), 179 (100), 121 (15).
Yield 78%; m.p.: 101–104 °C; 1H NMR (200 MHz,
CDCl3): d = 1.26 (t, 3H, H10), 3.58 (d, 1H,
2J = 18.8 Hz, H4a), 3.75 (d, 1H, 2J = 18.6 Hz, H4b),
3.79 (d, 1H, 2J = 16.1 Hz, H7a), 3.88 (d, 1H,
2J = 16.0 Hz, H7b), 4.22 (q, 2H, H9), 6.00 (br s, 1H,
OH), 7.40–7.77 (m, 9H, H–Ar) ppm; 13C NMR (100 MHz,
CDCl3): d = 14.0 (C10), 42.8 (C4), 43.5 (C7), 61.5 (C9),
91.4 (q, J = 34 Hz, C5), 123.0 (q, J = 287 Hz, CF3),
127.0, 127.1, 127.5, 128.2, 128.4, 128.5, 128.9, 139.7,
144.1 (C–Ar), 153.4 (C3), 166.6 (C6, C=O), 167.8 (C8,
C=O) ppm; MS (EI,70 eV): m/z (%) = 420 (M?, 39), 375
(14), 306 (100), 237 (91), 178 (26).
Ethyl 3-(4-chlorophenyl)-4,5-dihydro-5-hydroxy-
b-oxo-5-(trifluoromethyl)-1H-pyrazole-1-propanoate
(3i, C15H14ClF3N2O4)
2
1
1
Yield 77%; m.p.: 79–82 °C; H NMR (200 MHz, CDCl3):
d = 1.24 (t, 3H, H10), 3.53 (d, 1H, 2J = 19 Hz, H4a), 3.70
2
2
(d, 1H, J = 19 Hz, H4b), 3.76 (d, 1H, J = 16 Hz, H7a),
3.85 (d, 1H, 2J = 16 Hz, H7b), 4.20 (q, 2H, H9), 5.97 (br s,
1H, OH), 7.42 (d, 3J = 9 Hz, 2H, H–Ar), 7.61 (d,
3J = 9 Hz, 2H, H–Ar) ppm; 13C NMR (100 MHz, CDCl3):
d = 13.9 (C10), 42.7 (C4), 43.4 (C7), 61.5 (C9), 91.8 (q,
2J = 34 Hz, C5), 123.0 (q, 1J = 287 Hz, CF3), 127.8,
128.0, 129.2, 137.4 (C–Ar), 152.5 (C3), 166.5 (C6, C=O),
167.6 (C8, C=O) ppm; MS (EI, 70 eV): m/z (%) = 378
(M?, 19), 333 (13), 264 (100), 195 (83).
Acknowledgments The authors are grateful to Conselho Nacional
´
de Desenvolvimento Cientıfico e Tecnologico (CNPq procs. nos.
578426/2008-0; 471519/2009-0), Fundac¸a˜o de Amparo a Pesquisa do
´
`
Estado do Rio Grande do Sul (FAPERGS/CNPq-PRONEX Edital No.
008/2009, Proc. No. 10/0037-8), and Coordenac¸a˜o de Aperfeic¸oa-
´
mento de Pessoal de Nıvel Superior (CAPES/PROEX) for financial
support. The fellowships from CNPq (M.A.P.M., L.B., M.R.B.M.,
123